Caris Life Sciences Statistics
Total Valuation
CAI has a market cap or net worth of $7.37 billion. The enterprise value is $7.75 billion.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CAI has 277.93 million shares outstanding.
Current Share Class | 277.93M |
Shares Outstanding | 277.93M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.88% |
Owned by Insiders (%) | 48.53% |
Owned by Institutions (%) | 2.20% |
Float | 88.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.08 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 17.14 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05
Current Ratio | 1.05 |
Quick Ratio | 0.70 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.16 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -172.71% |
Revenue Per Employee | $255,793 |
Profits Per Employee | -$209,813 |
Employee Count | 1,769 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 3,193,959 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CAI had revenue of $452.50 million and -$371.16 million in losses. Loss per share was -$10.43.
Revenue | 452.50M |
Gross Profit | 211.38M |
Operating Income | -222.85M |
Pretax Income | -371.16M |
Net Income | -371.16M |
EBITDA | -184.60M |
EBIT | -222.85M |
Loss Per Share | -$10.43 |
Full Income Statement Balance Sheet
The company has $33.43 million in cash and $419.83 million in debt, giving a net cash position of -$386.40 million or -$1.39 per share.
Cash & Cash Equivalents | 33.43M |
Total Debt | 419.83M |
Net Cash | -386.40M |
Net Cash Per Share | -$1.39 |
Equity (Book Value) | -353.75M |
Book Value Per Share | -73.78 |
Working Capital | 8.68M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$202.61 million and capital expenditures -$9.40 million, giving a free cash flow of -$212.01 million.
Operating Cash Flow | -202.61M |
Capital Expenditures | -9.40M |
Free Cash Flow | -212.01M |
FCF Per Share | -$0.76 |
Full Cash Flow Statement Margins
Gross margin is 46.71%, with operating and profit margins of -49.25% and -60.43%.
Gross Margin | 46.71% |
Operating Margin | -49.25% |
Pretax Margin | -60.43% |
Profit Margin | -60.43% |
EBITDA Margin | -40.79% |
EBIT Margin | -49.25% |
FCF Margin | n/a |
Dividends & Yields
CAI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -5.04% |
FCF Yield | -2.88% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CAI has an Altman Z-Score of -13.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -13.34 |
Piotroski F-Score | 1 |